| Insider | Role | Shares | Value | Buys | Sells |
|---|---|---|---|---|---|
| Date | Ticker | Insider | Role | Type | Shares | Price | Value | Chg% | SEC |
|---|---|---|---|---|---|---|---|---|---|
| Insider | Role | Shares | Value | Buys | Sells |
|---|---|---|---|---|---|
| Date | Ticker | Insider | Role | Type | Shares | Price | Value | Chg% | SEC |
|---|---|---|---|---|---|---|---|---|---|
Across the last three months, Cogent Biosciences, Inc.'s insiders have reduced their positions by a net 45,510 shares worth roughly $1.7M.
Classified under Biotechnology (Health Care sector), COGT's insider flows are most useful compared with peers in the same group.
| Role | Insider | Shares | Value | 30d |
|---|---|---|---|---|
| CEO | 497.5K | - | - | |
| Other | 140.0K | $5.42M | - | |
| Other | 133.9K | $5.18M | - | |
| CFO | 131.8K | $5.10M | - | |
| Other | 109.4K | $4.23M | - |
Buys and sells only
| Date | Insider | Role | Type | Shares | Price | Value | Chg% | 3M | 12M | SEC |
|---|---|---|---|---|---|---|---|---|---|---|
| Aug 27, 2026 | Morris Arlene | Director | Sale+OE | 45,510 | $37.12 | $1,689,492.96 | -100% | - | - | |
| Mar 31, 2026 | Fairmount Funds Management LLC74 | Director | Sell | 7,000,000 | $34.66 | $242,620,000.00 | -56.0% | +0.6% | - | |
| Jan 22, 2026 | Fairmount Funds Management LLC74 | Director | Sell | 3,500,000 | $36.40 | $127,400,000.00 | -38.9% | -7.9% | - | |
| Dec 26, 2025 | Kearns Evan | Chief Legal Officer | Sell | 65,000 | $38.70 | $2,515,500.00 | -37.3% | -5.2% | - | |
| Dec 26, 2025 | Green John L. | Chief Financial Officer | Sell | 77,000 | $38.68 | $2,978,360.00 | -36.9% | -5.2% | - | |
| Dec 26, 2025 | Sachs Jessica | Chief Medical Officer | Sell | 82,642 | $38.70 | $3,198,245.40 | -38.2% | -5.2% | - | |
| Dec 26, 2025 | Robinson John Edward | Chief Scientific Officer | Sell | 90,000 | $38.74 | $3,486,600.00 | -39.1% | -5.2% | - | |
| Jul 10, 2025 | Fairmount Funds Management LLC74 | Director | Buy | 2,777,777 | $9.00 | $24,999,993.00 | +44.6% | +43.6% | +258.2% | |
| Jan 14, 2025 | Pinnow Cole | Chief Commercial Officer | Buy | 43,750 | $7.60 | $332,412.50 | +2,085% | -37.9% | +412.8% | |
| Jun 9, 2023 | Fairmount Funds Management LLC74 | 10% Owner, See Remarks | Buy | 800,000 | $12.00 | $9,600,000.00 | +32.4% | +0.5% | -30.1% |